A girl receives a dose of Biological E's COVID-19 vaccine, Corbevax, during a vaccination drive for children aged 12 to 14 inside a school in Ahmedabad, India, March 16, 2022. REUTERS
India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose in the country, the company said on Saturday.
The Drugs Controller General of India (DCGI) gave the nod for the Corbevax vaccine to be administerd as a booster shot to people age 18 years and over who have already received two doses of either AstraZeneca Plc's (AZN.L) Covishield or Bharat Biotech's Covaxin.
1714029027-0/Tribune-Collage-Feature-Images-(11)1714029027-0-270x192.webp)
1714027629-0/Ranbirtransformation-(1)1714027629-0-270x192.webp){kind=spacer}
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ